{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:45:23Z","timestamp":1787024723013,"version":"build-2736575974"},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2013]]},"DOI":"10.2169\/internalmedicine.52.0347","type":"journal-article","created":{"date-parts":[[2013,10,14]],"date-time":"2013-10-14T19:03:21Z","timestamp":1381777401000},"page":"2311-2315","source":"Crossref","is-referenced-by-count":16,"title":["Cyclophosphamide-induced Cardiotoxicity with a Prolonged Clinical Course Diagnosed on an Endomyocardial Biopsy"],"prefix":"10.2169","volume":"52","author":[{"given":"Saburo","family":"Kusumoto","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kawano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomayoshi","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nagasaki University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osami","family":"Satoh","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Japanese Red Cross Nagasaki Genbaku Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Yonekura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamichi","family":"Eguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Takeno","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Tsuneto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Koide","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Jo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Japanese Red Cross Nagasaki Genbaku Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Maemura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Gottdiener JS, Appelbaum FR, Ferrans VJ, Deisseroth A, Ziegler J. Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med 141: 758-763, 1981.","DOI":"10.1001\/archinte.1981.00340060066015"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Morandi P, Ruffini PA, Benvenuto GM, Raimondi R, Fosser V. Cardiac toxicity of high-dose chemotherapy. Bone Marrow Transplant 35: 323-334, 2005.","DOI":"10.1038\/sj.bmt.1704763"},{"key":"3","unstructured":"3. Goldberg MA, Antin JH, Guinan EC, Rappeport JM. Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood 68: 1114-1118, 1986."},{"key":"4","unstructured":"4. Pai VB, Nahata MC. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. Drug Saf 22: 263-302, 2000."},{"key":"5","unstructured":"5. Dow E, Schulman H, Agura E. Cyclophosphamide cardiac injury mimicking acute myocardial infarction. Bone Marrow Transplant 12: 169-172, 1993."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Katayama M, Imai Y, Hashimoto H, et al. Fulminant fatal cardiotoxicity following cyclophosphamide therapy. J Cardiol 54: 330-334, 2009.","DOI":"10.1016\/j.jjcc.2009.01.006"},{"key":"7","unstructured":"7. Yeh ET, Tong AT, Lenihan DJ, et al. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 109: 3122-3131, 2004."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Floyd JD, Nguyen DT, Lobins RL, Bashir Q, Doll DC, Perry MC. Cardiotoxicity of cancer therapy. J Clin Oncol 23: 7685-7696, 2005.","DOI":"10.1200\/JCO.2005.08.789"},{"key":"9","unstructured":"9. Yeh ET, Bickford CL. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol 53: 2231-2247, 2009."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sudharsan PT, Mythili Y, Selvakumar E, Varalakshmi P. Lupeol and its ester ameliorate the cyclophosphamide provoked cardiac lysosomal damage studied in rat. Mol Cell Biochem 282: 23-29, 2006.","DOI":"10.1007\/s11010-006-1169-1"},{"key":"11","unstructured":"11. Braverman AC, Antin JH, Plappert MT, Cook EF, Lee RT. Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. J Clin Oncol 9: 1215-1223, 1991."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Slørdal L, Spigset O. Heart failure induced by non-cardiac drugs. Drug Saf 29: 567-586, 2006.","DOI":"10.2165\/00002018-200629070-00003"},{"key":"13","unstructured":"13. Laskin BL, Goebel J, Davies SM, Jodele S. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood 118: 1452-1462, 2011."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yeh ET. Cardiotoxicity induced by chemotherapy and antibody therapy. Annu Rev Med 57: 485-498, 2006.","DOI":"10.1146\/annurev.med.57.121304.131240"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Quezado ZM, Wilson WH, Cunnion RE, et al. High-dose ifosfamide is associated with severe, reversible cardiac dysfunction. Ann Intern Med 118: 31-36, 1993.","DOI":"10.7326\/0003-4819-118-1-199301010-00006"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/20\/52_52.0347\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T13:46:45Z","timestamp":1621432005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/20\/52_52.0347\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":15,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.52.0347","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}